ArticleCureus2026
Transoral Laser Microsurgery Outcomes in Early-Stage Glottic Laryngeal Cancer at a Tertiary Center.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION AND
aimCurative treatment options for early-stage glottic laryngeal cancer include primary radiation therapy, open surgical techniques, and transoral laser microsurgery. In the last decade, transoral laser microsurgery has become a standard approach in many institutions due to its minimally invasive nature. This study aimed to evaluate the oncologic outcomes, complication rates, and therapeutic efficacy of transoral diode laser microsurgery in patients with early-stage (Tis, T1, T2) glottic laryngeal cancer. MATERIALS AND
methodsThe retrospective data of 52 patients treated with transoral diode laser microsurgery at the ENT Clinic of Zonguldak Bülent Ecevit University between January 2021 and December 2024 were analyzed. Patients' demographic characteristics, tumor stages, surgical margin status, postoperative complications, recurrence rates, and survival outcomes were evaluated.
resultsOf the 52 patients in the study, 25 were in Tis, 20 in T1, and seven in T2 stage. The mean age of the patients was 65.5 years; 94.2% were male, and 5.8% were female. The mean follow-up period was 25.3 months. The postoperative complication rate was 8%, and the most common complications were vocal cord edema and granuloma formation. The local recurrence rate was 9.6%. The recurrence rate was higher in patients with anterior commissure involvement. No patient required a tracheotomy.
conclusionTransoral diode laser microsurgery is an effective treatment modality for early-stage glottic laryngeal cancers with a low complication rate and short hospitalization period. The risk of recurrence is higher, especially in patients with anterior commissure involvement, and this patient group should be followed more closely.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.